Hrt Financial »

Lineage Cell Therapeutics In shares owned by Hrt Financial

Quarter-by-quarter ownership of Lineage Cell Therapeutics In (LCTX) shares owned by Hrt Financial from 13F filings

Historical chart of Hrt Financial investment in Lineage Cell Therapeutics In

Tip: Access up to 7 years of quarterly data

All positions including Lineage Cell Therapeutics In held by Hrt Financial consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Lineage Cell Therapeutics In by Hrt Financial

Quarter filed Position value Share count Share price at filing
2023-12-31 $39k 36k 1.09
2023-06-30 $1.0M 745k 1.41
2023-03-31 $374k 249k 1.50
2022-12-31 $23k 20k 1.14
2021-12-31 $330k 135k 2.44
2021-03-31 $679k 289k 2.35